Thomson Reuters (TRI) Q1 2026 Earnings Transcript

Thomson Reuters reported strong Q1 results with organic revenue up 8%, adjusted EBITDA up 9% to $881 million, adjusted EPS up 10% to $1.23, and free cash flow up 19% to $332 million. Management reaffirmed 2026 guidance for 7.5%-8% organic growth and about 40% adjusted EBITDA margin while highlighting accelerating AI adoption, with GenAI-enabled ACV reaching 30% and Westlaw Advantage/CoCounsel showing strong traction. The company also raised its dividend 10% for the fifth straight year and completed $262 million of buybacks plus a $605 million capital return, but signaled near-term government softness and higher interest expense.

Analysis

The setup is more interesting than a simple “AI beneficiary” story: TRI is converting product novelty into durable pricing power while keeping capital intensity low. The key second-order effect is that every point of AI-enabled ACV migration raises switching costs and lowers churn, because the workflow becomes embedded across research, drafting, tax prep, and compliance rather than sold as a point feature. That should support a higher long-run multiple versus traditional info-services peers, even if headline growth eventually moderates.

The market may still be underappreciating how this can expand TAM from the bottom up. Historically, premium legal workflow software sold top-down into large firms; now usage is spreading into smaller firms and mid-market corporate teams, which creates a broader seat-expansion model and improves sales efficiency. The beta-to-launch path for the next legal companion product is the near-term catalyst: if it lands as a workflow layer rather than a feature add-on, it can pull forward 2027 revenue and strengthen FY26/27 bookings momentum.

The main risk is margin optics, not demand. LLM costs, seasonality, and modest M&A dilution cap near-term EBITDA expansion, so investors chasing a straight-line margin story will be disappointed in Q2 even if the full-year target is intact. A more material medium-term risk is that enterprise AI vendors continue to compress model economics faster than TRI can monetize; the company is addressing this with its own legal model, but proof of cost advantage will matter over the next 2-4 quarters.

Consensus looks too focused on the dividend/buyback as the equity thesis. The real value creation lever is that TRI is becoming an AI-native workflow platform with recurring revenue characteristics, which should justify a premium relative to legacy information businesses and a discount to pure software names only if adoption stalls. If AI ACV keeps compounding at the current 2-3 point quarterly clip, the stock likely re-rates before the P&L fully catches up.

Key Decisions for Investors

• Go long TRI on any post-earnings digestion over the next 1-2 weeks; use weakness tied to Q2 margin concerns to build a core position. Risk/reward favors owning the name into the Q3 CoCounsel Legal launch, with upside from a 2027 revenue pull-forward and downside limited by recurring cash flow and capital returns.
• Pair trade: long TRI / short a legacy legal-information or broad data-services peer basket over 3-6 months. TRI has the clearest AI monetization path and better chance of sustaining revenue reacceleration, while slower-moving peers face similar AI narrative risk without comparable product adoption metrics.
• Buy TRI Jan-2027 call spreads on launch timing, targeting upside if CoCounsel Next drives an inflection in net sales and AI-enabled ACV. This is a cleaner expression than common stock if you expect a second-half product catalyst but want to define risk around LLM cost volatility.
• Avoid shorting TRI on the interest expense or Q2 margin noise alone. Those are largely mechanical and already guided; the real bear case would require evidence that AI adoption is plateauing, which is not visible in the current usage data.
• Set a tactical add level if TRI retraces on broader tech selloffs rather than company-specific fundamentals. The stock should command a quality-growth premium as long as ACV penetration keeps rising and government weakness remains isolated rather than spreading to core legal demand.